|
Cardiovascular Pharmacology
Citations 461-470 of 640 total displayed.
|
Past content
(since Jan 1999):
|
- Scientific Contributions
ACE Inhibition Versus Angiotensin Type 1 Receptor Antagonism: Differential Effects on PAI-1 Over Time
- Nancy J. Brown, Sandeep Kumar, Corrie A. Painter, and Douglas E. Vaughan
Hypertension 2002;40:859-865; published online before print as doi:10.1161/01.HYP.0000040264.15961.48
[Abstract]
[Full text]
- Scientific Contributions
Drug Effects on Aldosterone/Plasma Renin Activity Ratio in Primary Aldosteronism
- Paolo Mulatero, Franco Rabbia, Alberto Milan, Cristina Paglieri, Fulvio Morello, Livio Chiandussi, and Franco Veglio
Hypertension 2002;40:897-902; published online before print as doi:10.1161/01.HYP.0000038478.59760.41
[Abstract]
[Full text]
- Scientific Contributions
Effects of Doxazosin and Propranolol on A2A Adenosine Receptors in Essential Hypertension
- Katia Varani, Roberto Manfredini, Valeria Iannotta, Cecilia Pancaldi, Elena Cattabriga, Canan Uluoglu, Pier Andrea Borea, and Francesco Portaluppi
Hypertension 2002;40:909-913; published online before print as doi:10.1161/01.HYP.0000039505.79741.15
[Abstract]
[Full text]
- Scientific Contributions
Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular Failure
- Klaus Höcherl, Franziska Dreher, Armin Kurtz, and Michael Bucher
Hypertension 2002;40:947-953; published online before print as doi:10.1161/01.HYP.0000041221.13644.B9
[Abstract]
[Full text]
- Scientific Contributions
Long-Term Adrenomedullin Administration in Experimental Heart Failure
- Miriam T. Rademaker, Chris J. Charles, Eric A. Espiner, M. Gary Nicholls, and A. Mark Richards
Hypertension 2002;40:667-672; published online before print as doi:10.1161/01.HYP.0000037132.90640.26
[Abstract]
[Full text]
- Scientific Contributions
Role of Cyclooxygenase-2 in the Prolonged Regulation of Renal Function
- Francisco Roig, Maria T. Llinás, Ruth López, and F. Javier Salazar
Hypertension 2002;40:721-728; published online before print as doi:10.1161/01.HYP.0000036451.76323.29
[Abstract]
[Full text]
- Scientific Contributions
Leptin Induces Endothelial Cell Migration Through Akt, Which Is Inhibited by PPAR -Ligands
- Stephan Goetze, Anne Bungenstock, Cornelia Czupalla, Friedrich Eilers, Philipp Stawowy, Ulrich Kintscher, Chantel Spencer-Hänsch, Kristof Graf, Bernd Nürnberg, Ronald E. Law, Eckart Fleck, and Michael Gräfe
Hypertension 2002;40:748-754; published online before print as doi:10.1161/01.HYP.0000035522.63647.D3
[Abstract]
[Full text]
- Scientific Contributions
NAD(P)H Oxidase Inhibition Improves Endothelial Function in Rat and Human Blood Vessels
- Carlene A. Hamilton, M. Julia Brosnan, Sammy Al-Benna, Geoffrey Berg, and Anna F. Dominiczak
Hypertension 2002;40:755-762; published online before print as doi:10.1161/01.HYP.0000037063.90643.0B
[Abstract]
[Full text]
- Scientific Contributions
Interaction of Sildenafil With cAMP-Mediated Vasodilation In Vivo
- Christoph Schalcher, Karin Schad, Hans Peter Brunner-La Rocca, Ruth Schindler, Erwin Oechslin, Christoph Scharf, Gabor Suetsch, Osmund Bertel, and Wolfgang Kiowski
Hypertension 2002;40:763-767; published online before print as doi:10.1161/01.HYP.0000036027.71527.3E
[Abstract]
[Full text]
- Scientific Contributions
Cyclooxygenase-2 Inhibition Attenuates Lipopolysaccharide-Induced Cardiovascular Failure
- Klaus Höcherl, Franziska Dreher, Armin Kurtz, and Michael Bucher
Hypertension published October 28, 2002, doi:10.1161/01.HYP.0000041221.13644.B9
[Abstract]
|
|